Research programme: small molecule therapeutics - Evotec SE/Shionogi
Latest Information Update: 25 Sep 2019
At a glance
- Originator Evotec AG; Shionogi
- Developer Evotec SE; Shionogi
- Class Small molecules
- Mechanism of Action Protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Infections in Germany
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Germany
- 05 Oct 2010 Early research in Infections in Germany (unspecified route)